
Felipe Sierra
Chief Scientific Officer of the Hevolution Foundation, a non-profit organization based in Riyadh, Saudi Arabia, that provides grants and early-stage

Chief Scientific Officer of the Hevolution Foundation, a non-profit organization based in Riyadh, Saudi Arabia, that provides grants and early-stage

Scientific Director, National Institute on Aging (NIA), NIH – United States Dr. Luigi Ferrucci is a geriatrician and epidemiologist internationally

Director of the Institute for Aging Research at the Albert Einstein College of Medicine and president of The Academy for

Ricardo Álvarez-Cienfuegos holds dual degrees in Law and Business Administration from the Complutense University of Madrid and has an MBA

Carolina Hernández Peratta is a clinical biochemist with over 22 years of experience, specializing in Longevity Medicine and aging management.

Nicolas Randall is a Storytelling Professor at IE and a trusted advisor to senior executives on how to communicate strategic

Débora Nuevo Ejeda is a specialist in Internal Medicine, focusing on Longevity Medicine, Microbiota, and Anti-Aging Medicine. She currently leads

Vanesa Pytel Córdoba is a neurologist specializing in clinical neurology and non-invasive brain neuromodulation. She holds a PhD in Medical-Surgical

Sonia Tejada Solís is a neurosurgeon specialized in brain tumors, pediatric neurosurgery, and anti-aging medicine. She currently leads the Preventive

Dr. Mera is the Chief of Internal Medicine at SHA Spain, specializing in longevity, regenerative medicine, sleep, smoking cessation, and

Manuel Bonilla, Corporate Director of Innovation at SHA He has more than 20 years of experience in management positions; as

With more than 20 years of experience in the financial sector, Javier is currently Founder & Managing Director of Longevity

Giovanni Scapagnini, MD, PhD is a full professor of Clinical Nutrition at the University of University of Molise, Campobasso Trained

Stefan Christen, Metabolomics Researcher at Nestlé Research in Lausanne, Switzerland Stefan is a biologist by training with a PhD from

Specialist in Geriatrics. Head of the Geriatrics Department at Getafe University Hospital (Madrid) and Professor of Geriatrics at the Faculty

Pedro Ros is the Founder of SilverEconomy.com, a leading research centre and expert hub on longevity trends and the business

Doctor of Biology and Professor of Genetics at the University of Valencia. Manuel Pérez Alonso received his PhD in Biology

Guillermo Pérez-Solero is the CEO and founder of N-GENE and has extensive experience in the field of longevity, applying innovative

Ana Jimenez-Pastor is PhD in Artificial Intelligence (AI) applied to medical imaging by the Polytechnic University of Valencia. She is

Irene Martínez de Toda Cabeza is a researcher and professor at the Complutense University of Madrid. She leads the NeuroImmunolAge

Jean-Marc Lemaitre, PhD, is Research Director at INSERM and co-founder/co-director of the Institute for Regenerative Medicine and Biotherapies (IRMB) at

Dr. Barrantes holds a degree in Biology, with additional predoctoral studies in Systems Engineering and Biochemistry. He completed his doctoral

Molecular biologist and neuroscientist, currently working at Tetraneuron, a biotechnology company focused on developing innovative gene therapies to treat neurodegenerative

PhD in Chemistry and Director of the Biosensors in Neuroscience Laboratory. Valle Palomo graduated with a degree in Chemistry in

Undergraduate student at Harvard, studying computational neuroscience with a focus on brain aging. Nina Khera investiga los factores genéticos que

Medical doctor and specialist in nutrition and endocrinology, professor at the University of Granada, author of over 350 publications, and

PhD in Biology and scientific entrepreneur. Co-founder of Valentia Biopharma. Mari Carmen Álvarez es Dra. en Biología por la Universidad

Health communicator and creator of Fitness Revolucionario, one of the most influential Spanish-language projects on health, training, and nutrition. Marcos

Leslie Kenny, longevity expert based in Oxford and alumna of UC Berkeley and Harvard She founded Oxford Healthspan after reversing

Professor of Physiology at the University of Valencia. He leads the FRESHAGE group, which focuses on healthy aging, exercise, and

Medical doctor specializing in neurosurgery by the Hospital Gregorio Marañon in Madrid Dr. José Hernández Poveda is a medical doctor,

Associate Professor in Aging and Dementia at the University of Southampton Dr Daniele Magistro previously held academic posts at Nottingham

Having worked for 20 years as a lawyer, journalist and entrepreneur, Helena now devotes herself to what she always wanted

Alvaro Pascual-Leone, M.D., Ph.D., is professor of neurology at Harvard Medical School, and director of the Berenson-Allen Center for

Biogerontologist and principal investigator at Altos Labs. Recently, he has presented a universal clock that applies to all mammals. Biogerontologist

Molecular biologist. She holds the Robert and Renee Belfer Chair for the study of neurodegenerative diseases at the Albert Einstein

PhD at Harvard Medical School. Director of the Institute on Aging and Distinguished Professor of Medicine at the University of

Professor of Actuarial Statistics at the University of Barcelona. Main lines of research: longevity and dependency risk analysis, economics of

Director of Innovation in Biomedical Assessment in the Health Area of the Instituto de Biomecánica de Valencia (IBV). José David

Professor of Cellular and Integrative Physiology and the Barshop Institute for Longevity and Aging Studies at UT Health San Antonio.

First Professor of Immunology in the Valencian Community, he chairs the Valencian Society of Immunology (SVI). José Miguel Sempere Ortells,

Professor of Physiology at the University of Valencia. He leads the FRESHAGE group working on healthy ageing, exercise and Alzheimer’s

Professor of Molecular Medicine at the University of Leicester (UK) and at the Universitat Oberta de Catalunya (Spain). Salvador Macip

Senior researcher at ETH Zurich and senior director of AI and digital biomarker research at the Centre for Digital Health

Business and Innovation Director at Life Length SL (Madrid), a leading company in telomerase and telomere diagnostics. Enrique Samper Rodríguez

Founder and Director of the Centre for Human and Applied Physiological Sciences at King’s College London. Stephen Harridge is Professor

CEO of Tetraneuron, where she leads the development of innovative gene therapies for neurodegenerative diseases such as Alzheimer’s disease. Mari

Head of internal medicine, genomics and anti-ageing at SHA Wellness Clinic, a comprehensive and integrative health project. Vicente Mera, awarded

PhD in Biology and Professor of Genetics at the University of Valencia. Manuel Pérez Alonso holds a PhD in Biology

Degree in Medicine and Surgery from the Complutense University of Madrid Leading cardiologist with a long career in research and

Founder and CEO of BioViva Sciences USA Inc Elizabeth (Liz) Parrish MBA, is the Founder and CEO of BioViva Sciences

CEO and co-founder of Quibim Ángel Alberich is CEO and co-founder of Quibim, a global company specialized in the design

Clinical geneticist and technical director of Nuuma Genetics. Antonio Urbano is a clinical geneticist and technical director of Nuuma Genetics,

Head of the Longevity and Microbiota Unit at Olympia del Grupo Quirónsalud. Debora Nuevo is head of the Longevity and

Director of Institute IMDEA Alimentación. Ricardo Ramos is the Director of Institute IMDEA Alimentación, specialized in Precision Nutrition and Health,

Founder and CEO of Blueprint. Bryan Jonhson is founder and CEO of Blueprint, a project that has achieved metabolic health

Research Professor, CSIC; Institute of Neurosciences (CSIC-UMH)

Director, IVF Laboratory, Clínica Valencia

Founder & Chief Executive Officer, Chronomics

General Manager, Clínica Diagonal (Barcelona)

Vice President of Bioinformatics & AI, Lifebit

Professor and Researcher, University of Valencia

Editor-in-Chief, Genética Médica

Biologist and Co-Founder, NUA Biological Innovations

Researcher and Professor, University of Valencia

Founder & CEO, Eugenomic

Professor of Physiology, University of Valencia; Researcher at INCLIVA and CIBERER

Vice President Business Development, Health in Code; President, Biohub Valencia

Healthcare Executive; Former CEO, Ribera Health Group

Chief Technology Officer, Kanteron Systems

Executive Director, TECH Tokyo; Visiting Professor, Institute of Science Tokyo

Co-Founder, Alliance for Longevity Science, Arts & Entertainment (ALSAE)

President & Chief Science Officer, LEV Foundation

Founder & CEO, AgeCurve

Chief, Translational Gerontology Branch, National Institute on Aging (NIH, USA)

Doctor of Medicine. Specialist in Internal Medicine. Cardiovascular Risk Consultation. Internal Medicine Service. Palencia University Welfare Complex

Vice-president of the Valencian Society of Geriatrics and Gerontology. She currently works in a Hospital at Home Unit.

His team investigates the role of activity-driven gene expression and chromatin modifications in neuronal plasticity, learning and memory.

The main objective of her researching group is to understand the mechanisms regulating stem cell homeostasis and regenerative functions.

Leader of the Uhlirova Lab, that studies stress resilience and ageing in Drosophila intestine.

PhD in Biology from Universidad de Barcelona. Postdoctoral research in Harvard University and Tufts University.

Telecommunications Engineer from the Polytechnics University of Valencia (UPV). He works in the field of radiological image processing and analysis.

PhD in industrial engineering from the Polytechnic University of Valencia. Working now at the Biomechanics Institute of Valencia.

Professor of Human Anatomy at the Faculty of Medicine of the University of Murcia. Director of the Official Aging Research Institute of Murcia.

Dr. Jay Sarkar is a Co-Founder for Turn Biotechnologies, a Stanford-born biotechnology company focused on multifaceted age-reversal via epigenetic reprogramming.

Doctor specialising in Family and Community Healthcare. PhD in Pharmacology from the University of Valencia.

Entraigues Abramson has been part of SRF since its founding days (2009) and before that, part of Methuselah Foundation (co-founded by Dave Gobel and Dr. Aubrey de Grey).

He is Professor of the Foundations of Economic Analysis at the UNED, where he was Director of the International PhD School and where he currently coordinates the Doctoral Programme in Economics and Business.

Chair of the Gerontopole & Department of Geriatric Internal Medicine at the Toulouse University Hospital and member of INSERM UMR 1027, as well as chair of the WHO Collaborating Center for Frailty, Clinical Research and Geriatric Training.

Researcher in the Chronobiology Group of the University of Murcia on a project to understand the mechanisms associated with the ageing of the circadian system of vertebrate models.

He leads a UAM and IdiPAZ research group named with the acronym FARMAVASM, dedicated to the study of the mechanisms that produce deterioration of the vascular function in pathological conditions.

He is a co-founder and CEO at Senolytic Therapeutics Inc., a pharmaceutical company that develops a novel class of medicines by targeting senescence cells. He is also supporting investments and strategic partnerships at Life Biosciences Inc. in Europe.

Manuel Serrano obtained his PhD in 1991, from the Universidad Autónoma de Madrid. From 1991 to 1996, Serrano worked in the team of David Beach in Cold Spring Harbor Laboratory, NY. During this period, Serrano made his most important discovery with the identification and characterization of the gene p16.

Manuel Collado holds a PhD in Biology from the Universidad Autónoma de Madrid. Having previously worked in London, New York and at the Spanish National Cancer Research Centre (CNIO) in Madrid, he is currently at the Health Research Institute of Santiago de Compostela (IDIS).

In 2003 she received a European PhD degree from the Department of Physiology of the Faculty of Medicine of the University of Valencia.

Mari Carmen Gómez Cabrera gained her doctorate from the Department of Physiology of the University of Valencia in 2004 and received a thesis award.

Born in 1953, José Viña is Professor of Physiology at the University of Valencia. He obtained his PhD at Valencia University in 1976 and has honoris causa doctorates from the University of Rennes (France) and the University of Buenos Aires (Argentina).

PhD in Biochemistry and Molecular Biology. Ramón y Cajal National Award for Research, European Molecular Biology Organization (EMBO) Gold Medal for best European researcher under the age of 40.

PhD in Biology and Professor of Genetics at the University of Valencia. Communicator and scientist-entrepreneur with projects such as Sistemas Genómicos (Genomic Systems), Valentia BioPharma and Genomic Medicine Institute.

Graduated in Biomedical Sciences at the University of Navarra, Manuel Corpas has worked at the National Institute of Bioinformatics and the Sanger Institute of genome analysis.